885518-86-5 Usage
Description
1H-Indazole-6-carboxylic acid, 3-formyl-, methyl ester is a chemical compound with the molecular formula C10H9N3O3. It is a methyl ester derivative of 1H-indazole-6-carboxylic acid, which contains a formyl group at the 3-position of the indazole ring. 1H-Indazole-6-carboxylic acid, 3-formyl-, methyl ester is characterized by its potential applications in various chemical reactions and organic synthesis processes.
Uses
Used in Pharmaceutical Research:
1H-Indazole-6-carboxylic acid, 3-formyl-, methyl ester is used as a building block for the synthesis of complex organic molecules and pharmaceutical compounds. Its unique structure and functional groups make it a valuable component in the development of new drugs and therapeutic agents.
Used in Agrochemical Research:
In the agrochemical industry, 1H-Indazole-6-carboxylic acid, 3-formyl-, methyl ester is used as a starting material for the synthesis of various agrochemicals. Its versatility allows for the creation of compounds with potential applications in pest control, crop protection, and other agricultural areas.
Used in Material Science:
1H-Indazole-6-carboxylic acid, 3-formyl-, methyl ester is also utilized in the development of new materials and compounds. Its chemical properties and reactivity make it a promising candidate for use in the synthesis of advanced materials with unique properties and potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 885518-86-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,5,1 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 885518-86:
(8*8)+(7*8)+(6*5)+(5*5)+(4*1)+(3*8)+(2*8)+(1*6)=225
225 % 10 = 5
So 885518-86-5 is a valid CAS Registry Number.
885518-86-5Relevant articles and documents
NOVEL 2,5-SUBSTITUTED PYRIMIDINES AS PDE4 INHIBITORS
-
Page/Page column 87, (2016/02/10)
The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
